Aclaris Therapeutics Inc 401(K) Plan — Form 5500 plan (Aclaris Therapeutics Inc)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Aclaris Therapeutics Inc 401(K) Plan is a benefit plan reported by Aclaris Therapeutics Inc under EIN 46-0571712 and plan number 001. The latest loaded filing year is 2023. The filing reports 154 participants and $12,430,834 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Aclaris Therapeutics Inc
EIN
46-0571712
Plan number
001
Plan type
2
Location
Wayne, PA
Latest filing year
2023
Participants
154
End-of-year plan assets
$12,430,834

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023154H, C20241014091723NAL0025804065001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$12,430,834
Total liabilities (EOY)
$0
Net assets (EOY)
$12,430,834
Net assets (BOY)
$9,346,047

Income & contributions

Employer contributions
$707,520
Participant contributions
$1,712,221
Total contributions
$2,797,627
Total income / additions
$4,675,015

Expenses & distributions

Benefits paid
$1,553,142
Administrative expenses
$32,815
Total expenses
$1,590,228
Net increase / (decrease)
$3,084,787

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
T. Rowe Price Rps, Inc.NONE$32,815$02023
Pimco FundsNONE$0$02023
Alliance Global FundsNONE$0$02023
Prudential JennisonNONE$0$02023
American FundsNONE$0$02023
Tiaa-Cref FundsNONE$0$02023
FidelityNONE$0$02023
Principal FundsNONE$0$02023
Jp Morgan FundsNONE$0$02023
Janus FundsNONE$0$02023

Related Form 5500 pages